Lindsey A. Fitzgerald

Lindsey Fitzgerald practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Lindsey Fitzgerald's NPI, 1043606965, was assigned on April 7, 2015. Lindsey Fitzgerald graduated from Tufts University School of Medicine in 2015. Lindsey Fitzgerald holds Utah license 10092681-1205.

Lindsey Fitzgerald's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Lindsey Fitzgerald's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Lindsey Fitzgerald is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Lindsey Fitzgerald practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Lindsey Fitzgerald's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Lindsey Fitzgerald is licensed in Utah.

CMS data shows 404 Medicare services from Lindsey Fitzgerald across 5 procedure codes in 2024, for 91 Medicare patients. Medicare paid $20,456 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 91 Medicare patients who saw Lindsey Fitzgerald in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 62% have high cholesterol. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Lindsey Fitzgerald's median patient age at 74, with 37% women.

In 2024, Lindsey Fitzgerald wrote 267 Medicare Part D claims for 37 patients. 90% of them were for generic drugs. CMS names the drug for 174 of them, across 7 drugs with 11 or more claims each, at $184,730 in total drug cost. In 2023, CMS named 101 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Lindsey Fitzgerald for performance year 2024, reported as part of a group. Lindsey Fitzgerald accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Lindsey Fitzgerald as offering telehealth.

CMS Open Payments shows 7 general payments to Lindsey Fitzgerald from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. ADC Therapeutics America, Inc. paid the most, $272.

Lindsey Fitzgerald graduated from Tufts University School of Medicine in 2015.